Magdalena Svensson
Partner
Get their honest, personalized take on your startup.
Sign in to pitch Magdalena →At a glance
- Full Name
- Magdalena Svensson
- Title
- Partner — Partnership Fund investment team (Nordics & UK)
- Firm
- IK Partners (formerly IK Investment Partners)
- Firm Type
- Private equity (mid-market). Note: the source stub labelled her an "Angel Investor" focused on "Seed Round" — this is not supported by any source. She is a private-equity Partner, not an angel/seed investor.
- Investment Stage
- Established mid-market companies; minority "Partnership" (development-capital) investments, typically in businesses valued at €200m+
- Check Size
- Not individually disclosed; deployed via IK's Partnership Funds (IK PF I ~€300m, 2019; IK PF II €335m, 2022; IK PF III €500m, 2025)
- Target Company Profile
- Established, higher-mid-market businesses seeking a minority partner for growth, succession, or expansion capital
- Sector Focus
- Healthcare (specialist focus) and Business Services
- Geographic Focus
- Nordic countries and the UK (broader IK footprint across Northern Europe)
- Location
- Paris (with Nordic/Stockholm coverage)
Background
Magdalena Svensson is a Partner at IK Partners, a European private-equity firm with a roughly 30-year history and offices across Northern Europe. She joined IK in 2018 and leads coverage of the Partnership Fund investment team for the Nordic and UK regions, drawing on about 20 years of investment experience with a particular specialism in healthcare.
Before IK, Svensson built a career across European growth and buyout investing. She was a Partner at Keensight Capital, a growth-equity firm active in healthcare and technology, and earlier a Partner at XAnge Private Equity. She began her investment career at ABN AMRO Capital. This trajectory — from a bank-affiliated PE arm through growth equity to a mid-market minority-investment platform — underpins her focus on partnering with established, founder- or management-led businesses rather than early-stage startups.
She holds an MBA from INSEAD in Paris and an MSc in Economics and Commercial Law from the University of Gothenburg. She is based in Paris while covering the Nordic and UK markets for IK's Partnership Fund strategy.
Within IK, the Partnership Fund strategy (launched 2019) sits apart from the firm's flagship buyout funds: it makes minority investments in more established, higher-end mid-market companies (typically €200m+ enterprise value), giving founders and management teams growth capital and liquidity without a full change of control. Svensson has served as an Advisor to IK Partnership Fund II.
Investment Thesis & Focus
- Invests through IK's Partnership Fund strategy: minority stakes in established higher-mid-market companies (typically €200m+ valuation), not seed or venture deals.
- Sector specialism in healthcare — IK targets healthcare businesses "driven by demographic factors, limited by public healthcare budget constraints and experiencing increased demand for consumerisation and quality of care" — plus business services.
- Provides partnership/development capital for growth, international expansion, buy-and-build, and shareholder succession, working alongside existing owners and management rather than replacing them.
- Deals are done as consortia or minority co-investments (e.g., alongside GIC, Keensight, Parquest on Unither), signalling a collaborative, non-controlling posture.
- Geographic remit: Nordic countries and the UK within IK's wider Northern-European platform.
Notable Investments
- Unither Pharmaceuticals (March 2023) — European pharmaceutical CDMO and global market leader in Blow-Fill-Seal (BFS) sterile liquid formulations. IK Partners and GIC entered the equity (buying stakes from Ardian), with Keensight Capital and Parquest reinforcing existing positions, in a management-led consortium under CEO Eric Goupil. Svensson (Partner and Advisor to IK Partnership Fund II) publicly commented on the deal, highlighting Unither's global BFS leadership.
Unlock the full research
Get how to approach them, recent activity, sources, contact links — plus pitch their AI twin for a candid read on your raise.
One-time. Stays unlocked for you.